QA: Rezolute Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2019_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001509261, Rezolute Inc

  xvar xval
0 AssetsCurrent 2,008,000
1 IntangibleAssetsNetIncludingGoodwill 37,000
2 PropertyPlantAndEquipmentNet 368,000
3 remainder_Assets 90,000
4 LiabilitiesCurrent 6,248,000
5 LiabilitiesNoncurrent 216,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,251,581
9 ResearchAndDevelopmentExpense 39,342,166
10 remainder_Expenses 1,544,816
11 remainder_Revenues 0
12 remainder_NetIncome -838,604
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,503,000
1 Liabilities 6,464,000
2 Expenses 50,138,563
3 Revenues 0
4 StockholdersEquity -3,961,000
5 NetIncome -50,977,167
6 ComprehensiveNetIncome -50,977,167
7 BaseVar 29,972,084
8 EconomicCapitalRatiobeforeLimitedLiability -13.3
9 EconomicCapitalRatio 0.00000102

Edgar->Model Mapping

Feature Distribution

Change over Time